Brooks Laboratories Limited

BROOKS

INE650L01011

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 05:13:51 27/05/2024 pm IST			5-day change	1st Jan Change
87.3 ^INR	-2.95%		-3.48%	-39.21%

18/05	Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
18/05	Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Brooks Laboratories Limited Announces Resignation of Kaushalya Singh as Whole Time Director

August 23, 2023 at 04:17 pm IST

Brooks Laboratories Limited announced that Mrs. Kaushalya Singh resigned as Whole Time Director of the Company w.e.f. closing of business hours of August 23, 2023.

Latest news about Brooks Laboratories Limited

Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024	18/05	CI
Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	18/05	CI
Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	31/01	CI
Brooks Laboratories Board to Consider Raising Funds Via Equity, Debt	17/01	MT
Brooks Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11	CI
Brooks Laboratories Limited Announces Director Appointments	21/23/21	CI
Brooks Laboratories Limited Announces Resignation of Kaushalya Singh as Whole Time Director	23/23/23	CI
Brooks Laboratories Limited Approves the Appointment of Bhushan Singh Rana as an Additional Director	23/23/23	CI
Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/23/10	CI
Brooks Laboratories Limited Appoints Durga Shankar Maity as Additional Director	07/23/07	CI
Brooks Laboratories Limited Announces Resignation of Manpreet Singh Naroo as Whole Time Director	07/23/07	CI
Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	29/23/29	CI
Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/23/14	CI
Brooks Laboratories Limited Announces Appointment of Jitendra Pratap Singh as A Whole Time Director	31/22/31	CI
Brooks Laboratories Limited Appoints Kaushalya Singh as a Whole Time Director of the Company	31/22/31	CI

Chart Brooks Laboratories Limited

Duration

Period

More charts

Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company working on a contract basis. The Company operates through the Pharmaceuticals segment. It manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup and eye/ear drops. Its products under Carbapenem category includes Imipenem 250mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 125mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, Doripenem 500mg and Doripenem 1000mg. It offers Penicillins in the form of injections, tablets and dry syrup. Its General category of products include liquid injections, dry powder injections and eye/ear drops. Its liquid injections include Iron sucrose 100mg/5ml, among others. The Company has manufacturing plants at Baddi, Himachal Pradesh. The Company manufactures and markets the pharmaceuticals nationally and internationally to various regulated markets.

Sector

Pharmaceuticals

Calendar

09/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BROOKS LABORATORIES LIMITED	-39.21%	28.42M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.40%	42.95B
OTSUKA HOLDINGS CO., LTD.	+16.28%	21.38B
SANDOZ GROUP AG	+20.14%	15.05B
CIPLA LIMITED	+18.64%	14.45B
ZYDUS LIFESCIENCES LIMITED	+53.58%	13.04B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.50%	6.72B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+11.64%	5.47B